|
|
Article: Research and Markets: Therapeutic Monoclonal Antibodies Markets Report Reviews the Market for Medical Products Based On Emerging Therapeutic Monoclonal Antibodies.
- Article from:
- Business Wire
- Article date:
- June 3, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/1d5546/therapeutic_monocl) has announced the addition of the "Therapeutic Monoclonal Antibodies Markets" report to their offering.
Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through recombinant DNA technology that has the ability to combine specifically with a target protein that plays a role in a disease process. With this unique ability to specifically target diseased cells while leaving ...